Zielen, S; Aberer, W; Lassmann, S; Wade, A; Kluehr, K; Raab, J; Lee, D; Ballard, R; Jones, C; Gunawardena, K; Kramer, MF; Skinner, MA; Hingebottam, T; De Kam, P.
Strong dose-response on immunoglobulin markers during a phase II allergen immunotherapy study with subcutaneously administered tyrosine adsorbed modified grass allergen plus MPL
ALLERGY. 2019; 74: 686-686.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Poster]
Web of Science